Association between Phosphorylated AMP-Activated Protein Kinase and MAPK3/1 Expression and Prognosis for Patients with Gastric Cancer
暂无分享,去创建一个
Sung Yong Oh | Su-jin Kim | S. Oh | Y. Chae | Min Chan Kim | You Jin Lee | Soo Jung Lee | Su-Jin Kim | Ki Han Kim | Yee Soo Chae | Byung Woog Kang | Jong Gwang Kim | B. Kang
[1] J. Ha,et al. AMP-activated protein kinase modulators: a patent review (2006 – 2010) , 2011, Expert opinion on therapeutic patents.
[2] D. Richardson,et al. AMP-activated protein kinase: a cellular energy sensor with a key role in metabolic disorders and in cancer. , 2011, Biochemical Society transactions.
[3] B. Viollet,et al. Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. , 2007, Cancer research.
[4] G. Merlino,et al. Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAFV600E , 2009, PloS one.
[5] S. Lippman,et al. The impact of phosphorylated AMP-activated protein kinase expression on lung cancer survival. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[6] C. Balch,et al. AJCC Cancer Staging Manual. 6th ed , 2002 .
[7] V. Steele,et al. Energy Homeostasis and Cancer Prevention: The AMP-Activated Protein Kinase , 2009, Cancer Prevention Research.
[8] I. Kang,et al. AMP-activated Protein Kinase Antagonizes Pro-apoptotic Extracellular Signal-regulated Kinase Activation by Inducing Dual-specificity Protein Phosphatases in Response to Glucose Deprivation in HCT116 Carcinoma* , 2010, The Journal of Biological Chemistry.
[9] Philip R Quinlan,et al. Histological evaluation of AMPK signalling in primary breast cancer , 2009, BMC Cancer.
[10] Nahum Sonenberg,et al. The Effects of Adiponectin and Metformin on Prostate and Colon Neoplasia Involve Activation of AMP-Activated Protein Kinase , 2008, Cancer Prevention Research.
[11] H. Clevers,et al. Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer , 2007, Oncogene.
[12] D. Carling,et al. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: inhibition by the AMP-activated protein kinase activation. , 2002, Diabetes.
[13] H. Ngan,et al. Inhibition of Cervical Cancer Cell Growth through Activation of Upstream Kinases of AMP-Activated Protein Kinase , 2009, Tumor Biology.
[14] R. Shaw,et al. The LKB1–AMPK pathway: metabolism and growth control in tumour suppression , 2009, Nature Reviews Cancer.
[15] A. Fornace,et al. AMP-activated protein kinase promotes human prostate cancer cell growth and survival , 2009, Molecular Cancer Therapeutics.
[16] O. Fiehn,et al. Prognostic impact of AMP-activated protein kinase expression in ovarian carcinoma: correlation of protein expression and GC/TOF-MS-based metabolomics. , 2011, Oncology reports.
[17] M. Loda,et al. Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer , 2010, British Journal of Cancer.
[18] Ming Tan,et al. Emerging metabolic targets in cancer therapy. , 2011, Frontiers in bioscience.
[19] K. Dahlman-Wright,et al. Metabolic diseases and cancer risk , 2012, Current opinion in oncology.
[20] K. Inoki,et al. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. , 2009, Human molecular genetics.
[21] J. Ha,et al. Screening methods for AMP-activated protein kinase modulators: a patent review , 2015, Expert opinion on therapeutic patents.
[22] Takafumi Ando,et al. Prevalence and prognosis of gastric cancer detected by screening in a large Japanese population: Data from a single institute over 30 years , 2007, Journal of gastroenterology and hepatology.
[23] Li Zhang,et al. Prognostic Associations of Activated Mitogen-Activated Protein Kinase and Akt Pathways in Glioblastoma , 2006, Clinical Cancer Research.
[24] T. Löning,et al. Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer , 2005, British Journal of Cancer.
[25] J. Chen,et al. Multiple signal pathways in obesity‐associated cancer , 2011, Obesity reviews : an official journal of the International Association for the Study of Obesity.
[26] Suzanne Schubbert,et al. Hyperactive Ras in developmental disorders and cancer , 2007, Nature Reviews Cancer.
[27] K. Guan,et al. AMP‐activated protein kinase and cancer , 2009, Acta physiologica.